Juvena is delighted to have had the opportunity to participate in our investor Bison’s AGM. CEO Dr. Yousef was on a panel focused on discussing the latest innovations in AI-driven drug discovery and development
We are thrilled to share that our Director of Discovery and Platform, Thach Mai, PhD, and our Director of Translational Biology, Priya Handa, PhD, represented Juvena Therapeutics at the 16th Drug Discovery Strategic Summit in San Francisco.
CEO Dr. Hanadie Yousef discusses Juvena’s AI-enabled proteomics and multimodal platform for decoding therapeutic secreted proteins on the “Leveraging Technology to Advance the Pipeline” panel at Longwood’s Boston CEO summit
CEO Dr. Hanadie Yousef was nominated to Founders Forum’s 100 Women Founders to Watch, which shines a light on 100 of the most exceptional women founders blazing a trail in the tech industry across UK & Europe, the United States, and Southeast Asia
CEO, Dr. Hanadie Yousef inspires the next generation of biotech entrepreneurs, in a fireside chat: Targeting the biology of aging to rejuvenate lives- Dr. Yousef’s journey through science research to launching Juvena for the Global Biotech Revolution
Juvena shares updates with the DM community about our muscle regenerating fusion protein, JUV-161 in the “Meet the Myotonic Dystrophy Drug Developers” webinar
CEO Dr. Yousef represents Juvena as a Technology Pioneer at at the World Economic Forum’s Annual Meeting of the New Champions, a.k.a. Summer Davos, in Dalian, China, speaking on “Revolutionary Remedies” and “Letting Biotech Breath”
CEO Dr. Yousef represents Juvena as a Technology Pioneer at at the World Economic Forum’s Annual Meeting of the New Champions, a.k.a. Summer Davos, in Dalian, China, speaking on “Revolutionary Remedies” and “Letting Biotech Breath”
